Trial · NCT00041938
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Event Rate Per 100 Patient Years for Composite Endpoint of Ischemic Stroke, Intracerebral Hemorrhage, or Death | Aspirin | 7.93 | events per 100 patient-years | ||
| Event Rate Per 100 Patient Years for Composite Endpoint of Ischemic Stroke, Intracerebral Hemorrhage, or Death | Warfarin | 7.47 | events per 100 patient-years | ||
| Event Rate Per 100 Patient-years for Composite Endpoint of Hospitalization for Heart Failure, Myocardial Infarction, Ischemic Stroke, Intracerebral Hemorrhage, or Death. | Aspirin | 12.15 | events per 100 patient-years | ||
| Event Rate Per 100 Patient-years for Composite Endpoint of Hospitalization for Heart Failure, Myocardial Infarction, Ischemic Stroke, Intracerebral Hemorrhage, or Death. | Warfarin | 12.70 | events per 100 patient-years | ||
| Event Rate Per 100 Patient-years for Ischemic Stroke | Aspirin | 1.36 | rate per 100 patient years | ||
| Event Rate Per 100 Patient-years for Ischemic Stroke | Warfarin | 0.72 | rate per 100 patient years | ||
| Event Rate Per 100 Patient-years for Intracerebral Hemorrhage | Aspirin | 0.05 | rate per 100 patient years | ||
| Event Rate Per 100 Patient-years for Intracerebral Hemorrhage | Warfarin | 0.12 | rate per 100 patient years | ||
| Event Rate Per 100 Patient-years for Death | Aspirin | 6.52 | events per 100 patient-years | ||
| Event Rate Per 100 Patient-years for Death | Warfarin | 6.63 | events per 100 patient-years | ||
| Event Rate Per 100 Patient Years of Myocardial Infarction Component of Secondary Composite Outcome | Aspirin | 0.87 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Myocardial Infarction Component of Secondary Composite Outcome | Warfarin | 0.80 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Heart Failure Hospitalization Component of Secondary Composite Outcome. | Aspirin | 5.67 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Heart Failure Hospitalization Component of Secondary Composite Outcome. | Warfarin | 6.79 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Ischemic Stroke Component of Secondary Composite Outcome | Aspirin | 1.14 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Ischemic Stroke Component of Secondary Composite Outcome | Warfarin | 0.57 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Intracerebral Hemorrhage Component of Secondary Composite Outcome | Aspirin | 0.06 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Intracerebral Hemorrhage Component of Secondary Composite Outcome | Warfarin | 0.11 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Death Component of Secondary Composite Outcome | Aspirin | 4.41 | events per 100 patient years | ||
| Event Rate Per 100 Patient Years of Death Component of Secondary Composite Outcome | Warfarin | 4.43 | events per 100 patient years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00041938/results